M. Andersson, J. Alvarez-cermeño, G. Bernardi, I. Cogato, P. Fredman et al., Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.8, pp.897-902, 1994.
DOI : 10.1136/jnnp.57.8.897

L. Barcellos, S. Sawcer, P. Ramsay, S. Baranzini, G. Thomson et al., Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis, Human Molecular Genetics, vol.25, issue.Pt 6, pp.2813-2837, 2006.
DOI : 10.1002/gepi.10258

F. Barkhof, M. Filippi, D. Miller, P. Scheltens, A. Campi et al., Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-69, 1997.
DOI : 10.1093/brain/120.11.2059

A. Bartos, L. Fialová, J. Soukupová, J. Kukal, I. Malbohan et al., Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis, Journal of Neurology, vol.50, issue.Pt 3, pp.20-25, 2007.
DOI : 10.1212/WNL.50.5.1282

J. Bednárová, P. Stourac, and P. Adam, Relevance of immunological variables in neuroborreliosis and multiple sclerosis, Acta Neurologica Scandinavica, vol.116, issue.2, pp.97-102, 2005.
DOI : 10.1212/WNL.51.3.885

G. Benedek, T. Paperna, N. Avidan, I. Lejbkowicz, J. Oksenberg et al., Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel, Genes & Immunity, vol.33, issue.5, pp.423-454, 2010.
DOI : 10.1198/106186002760180590

R. Berland and H. Wortis, CD5, Annual Review of Immunology, vol.20, issue.1, pp.253-300, 2001.
DOI : 10.1146/annurev.immunol.20.100301.064833

M. Boes, Role of natural and immune IgM antibodies in immune responses, Molecular Immunology, vol.37, issue.18, pp.1141-1150, 2000.
DOI : 10.1016/S0161-5890(01)00025-6

P. Bongioanni, C. Fioretti, R. Vanacore, F. Bianchi, F. Lombardo et al., Lymphocyte subsets in multiple sclerosis A study with two-colour fluorescence analysis, Journal of the Neurological Sciences, vol.139, issue.1
DOI : 10.1016/0022-510X(96)00030-5

I. Bosca, L. Villar, F. Coret, M. Magraner, M. Simó-castelló et al., Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands. Mult Scler, pp.810-815, 2010.

I. Boscá, M. Magraner, F. Coret, J. Alvarez-cermeño, M. Simó-castelló et al., The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands, Journal of Neuroimmunology, vol.226, issue.1-2, pp.143-149, 2010.
DOI : 10.1016/j.jneuroim.2010.05.032

E. Breij, B. Brink, R. Veerhuis, C. Van-den-berg, R. Vloet et al., Homogeneity of active demyelinating lesions in established multiple sclerosis, Annals of Neurology, vol.143, issue.pt 4
DOI : 10.1042/bj2640001

S. Cepok, B. Rosche, V. Grummel, F. Vogel, D. Zhou et al., Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis, Brain, vol.128, issue.7, pp.1667-76, 2005.
DOI : 10.1093/brain/awh486

I. Charo and R. Ransohoff, The Many Roles of Chemokines and Chemokine Receptors in Inflammation, New England Journal of Medicine, vol.354, issue.6, pp.610-631, 2006.
DOI : 10.1056/NEJMra052723

C. Confavreux, C. Caudie, F. Touraine, J. Ventre, G. Aimard et al., Plasma cells in cerebrospinal fluid and multiple sclerosis: diagnostic yield and clinicobiological correlations, Acta Neurologica Scandinavica, vol.13, issue.No 599, pp.432-440, 1986.
DOI : 10.1212/WNL.33.5.611

A. Corcione, S. Casazza, E. Ferretti, D. Giunti, E. Zappia et al., Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis, Proceedings of the National Academy of Sciences, vol.86, issue.1, pp.11064-11073, 2004.
DOI : 10.1016/S0165-5728(98)00002-2

J. Correale and M. De-los-milagros-bassani-molinas, Oligoclonal bands and antibody responses in Multiple Sclerosis, Journal of Neurology, vol.249, issue.4, pp.375-89, 2002.
DOI : 10.1007/s004150200026

G. Davies, G. Keir, E. Thompson, and G. Giovannoni, The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up study, Neurology, vol.60, issue.7, pp.1163-1169, 2003.
DOI : 10.1212/01.WNL.0000055864.08740.CB

M. Debouverie, S. Louis, S. Pittion, T. Roederer, and H. Vespignani, Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France, Journal of Neurology, vol.10, issue.10, p.1370, 2007.
DOI : 10.1212/01.wnl.0000188880.17038.1d

E. Frohman, M. Racke, and C. Raine, Multiple Sclerosis ??? The Plaque and Its Pathogenesis, New England Journal of Medicine, vol.354, issue.9, pp.942-55, 2006.
DOI : 10.1056/NEJMra052130

N. García-barragán, L. Villar, M. Espiño, M. Sádaba, P. González-porqué et al., Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment, European Journal of Neurology, vol.12, issue.3, 2009.
DOI : 10.1159/000103643

F. Gay, T. Drye, G. Dick, and M. Esiri, The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion, Brain, vol.120, issue.8, pp.1461-83, 1997.
DOI : 10.1093/brain/120.8.1461

C. Genain, B. Cannella, S. Hauser, and C. Raine, Identification of autoantibodies associated with myelin damage in multiple sclerosis, Nature Medicine, vol.63, issue.2, pp.170-175, 1999.
DOI : 10.1046/j.1471-4159.1994.63062353.x

M. Gunnarsson, C. Malmeström, M. Axelsson, P. Sundström, C. Dahle et al., Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab, Annals of Neurology, vol.14, issue.pt 8, pp.83-92, 2010.
DOI : 10.1177/1352458507082061

S. Hauser, E. Waubant, D. Arnold, T. Vollmer, J. Antel et al., B-Cell Depletion with Rituximab in Relapsing???Remitting Multiple Sclerosis, New England Journal of Medicine, vol.358, issue.7, pp.676-88, 2008.
DOI : 10.1056/NEJMoa0706383

O. Howell, C. Reeves, R. Nicholas, D. Carassiti, B. Radotra et al., Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis, Brain, vol.80, issue.9, pp.2755-71, 2011.
DOI : 10.1136/jnnp.2008.154906

M. Hutchinson, CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: Commentary, Multiple Sclerosis Journal, vol.19, issue.6, pp.719-739, 2013.
DOI : 10.1136/jnnp.2008.150896

K. Imrell, A. Landtblom, J. Hillert, and T. Masterman, Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct, Neurology, vol.67, issue.6, pp.1062-1066, 2006.
DOI : 10.1212/01.wnl.0000237343.93389.35

M. Janeway, T. Walport, and . Immunobiologie, Traduction de la 7 ème édition anglaise par Pierre L. Masson, 2009.

P. Jongen, L. Nijeholt, G. Lamers, K. Doesburg, W. Barkhof et al., Cerebrospinal Fluid IgM Index Correlates with Cranial MRI Lesion Load in Patients with Multiple Sclerosis, European Neurology, vol.58, issue.2, pp.90-95, 2007.
DOI : 10.1159/000103643

L. Kappos, D. Li, P. Calabresi, O. Connor, P. Bar-or et al., Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial, The Lancet, vol.378, issue.9805, pp.1779-87, 2011.
DOI : 10.1016/S0140-6736(11)61649-8

S. Kelly, K. Kinsella, M. Duggan, N. Tubridy, C. Mcguigan et al., A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis, Multiple Sclerosis Journal, vol.19, issue.8
DOI : 10.1212/01.WNL.0000151852.15294.CB

M. Khademi, I. Kockum, M. Andersson, E. Iacobaeus, L. Brundin et al., Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course, Multiple Sclerosis Journal, vol.17, issue.3, pp.335-378, 2010.
DOI : 10.1001/archneurol.2010.99

M. Kowarik, S. Cepok, J. Sellner, V. Grummel, M. Weber et al., CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation, Journal of Neuroinflammation, vol.76, issue.1, pp.93-103, 2012.
DOI : 10.1212/WNL.0b013e3182143564

M. Krumbholz, D. Theil, T. Derfuss, A. Rosenwald, F. Schrader et al., BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma, The Journal of Experimental Medicine, vol.161, issue.2, pp.195-200, 2005.
DOI : 10.1002/jnr.490320405

M. Krumbholz, D. Theil, S. Cepok, B. Hemmer, P. Kivisäkk et al., Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment, Brain, vol.129, issue.1, pp.200-211, 2005.
DOI : 10.1038/nn1127

M. Krumbholz, T. Derfuss, R. Hohlfeld, and E. Meinl, B cells and antibodies in multiple sclerosis pathogenesis and therapy, Nature Reviews Neurology, vol.25, issue.11, pp.613-636, 2009.
DOI : 10.1016/j.jaut.2005.08.004

B. Kuenz, A. Lutterotti, R. Ehling, C. Gneiss, M. Haemmerle et al., Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One, 2008.

H. Lassmann, K. Kitz, and H. Wisniewski, In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin, Acta Neuropathologica, vol.1, issue.Suppl, pp.297-306, 1981.
DOI : 10.1007/BF00690994

E. Leray, J. Yaouanq, L. Page, E. Coustans, M. Laplaud et al., Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.67, issue.5, pp.1900-1913, 2010.
DOI : 10.1212/01.wnl.0000234064.17156.03

M. Lincoln, S. Ramagopalan, M. Chao, B. Herrera, G. Deluca et al., Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility, Proceedings of the National Academy of Sciences, vol.52, issue.3, pp.7542-7549, 2009.
DOI : 10.1017/S0317167100034041

URL : http://www.pnas.org/content/106/18/7542.full.pdf

R. Lindberg, L. Achtnichts, F. Hoffmann, J. Kuhle, and L. Kappos, Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients, Journal of Neuroimmunology, vol.194, issue.1-2, pp.153-64, 2008.
DOI : 10.1016/j.jneuroim.2007.11.007

H. Link and Y. Huang, Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness, Journal of Neuroimmunology, vol.180, issue.1-2, pp.17-28, 2006.
DOI : 10.1016/j.jneuroim.2006.07.006

P. Lourenco, A. Shirani, J. Saeedi, J. Oger, W. Schreiber et al., Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression, Multiple Sclerosis Journal, vol.29, issue.5, 2013.
DOI : 10.1212/WNL.0b013e3182190f74

L. Lovato, S. Willis, S. Rodig, T. Caron, S. Almendinger et al., Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis, Brain, vol.182, issue.2, pp.534-575, 2011.
DOI : 10.4049/jimmunol.0803424

C. Lucchinetti, B. Popescu, R. Bunyan, N. Moll, S. Roemer et al., Inflammatory Cortical Demyelination in Early Multiple Sclerosis, New England Journal of Medicine, vol.365, issue.23, pp.2188-97, 1056.
DOI : 10.1056/NEJMoa1100648

R. Luxton, B. Mclean, and E. Thompson, Isoelectric focusing versus quantitative measurements in the detection of intrathecal local synthesis of IgG, Clinica Chimica Acta, vol.187, issue.3, pp.297-308, 1990.
DOI : 10.1016/0009-8981(90)90115-9

M. Mehling, J. Kuhle, and A. Regeniter, 10 Most Commonly Asked Questions About Cerebrospinal Fluid Characteristics in Demyelinating Disorders of the Central Nervous System, The Neurologist, vol.14, issue.1, pp.60-65, 2008.
DOI : 10.1097/NRL.0b013e31815ac523

E. Meinl, M. Krumbholz, and R. Hohlfeld, B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation, Annals of Neurology, vol.64, issue.6, pp.880-92, 2006.
DOI : 10.1212/01.WNL.0000159399.81861.D5

I. Mero, M. Gustavsen, H. Saether, S. Flåm, P. Berg-hansen et al., International Multiple Sclerosis Genetics Consortium Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles, PLoS One, vol.8, issue.3, 2013.

D. Miller, D. Chard, and O. Ciccarelli, Clinically isolated syndromes, The Lancet Neurology, vol.11, issue.2, pp.157-69
DOI : 10.1016/S1474-4422(11)70274-5

URL : https://hal.archives-ouvertes.fr/hal-00552764

E. Mix, T. Olsson, J. Correale, S. Baig, V. Kostulas et al., B cells expressing CD5 are increased in cerebrospinal fluidof patients with multiple sclerosis, Clinical & Experimental Immunology, vol.17, issue.Suppl. 28, pp.21-28, 1990.
DOI : 10.3109/00365517709091496

D. Moulin, D. Paty, and G. Ebers, THE PREDICTIVE VALUE OF CEREBROSPINAL FLUID ELECTROPHORESIS IN ???POSSIBLE??? MULTIPLE SCLEROSIS, Brain, vol.106, issue.4, pp.809-825, 1983.
DOI : 10.1093/brain/106.4.809

M. Niino, C. Bodner, M. Simard, S. Alatab, D. Gano et al., Natalizumab effects on immune cell responses in multiple sclerosis, Annals of Neurology, vol.182, issue.5, pp.748-54, 2006.
DOI : 10.4049/jimmunol.168.1.499

B. Obermeier, L. Lovato, R. Mentele, W. Brück, I. Forne et al., Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin, Journal of Neuroimmunology, vol.233, issue.1-2, pp.245-253, 2011.
DOI : 10.1016/j.jneuroim.2011.01.010

S. Ousman, B. Tomooka, J. Van-noort, E. Wawrousek, O. Connor et al., Protective and therapeutic role for ??B-crystallin in autoimmune demyelination, Nature, vol.95, issue.7152, pp.474-483, 2007.
DOI : 10.4049/jimmunol.164.8.4359

L. Pereira-mouriès, M. Almeida, C. Ribeiro, J. Peduzzi, M. Barthélemy et al., Soluble silk-like organic matrix in the nacreous layer of the bivalve Pinctada maxima, European Journal of Biochemistry, vol.132, issue.20
DOI : 10.1016/S1096-4959(01)00524-3

P. Perini, F. Ranzato, M. Calabrese, L. Battistin, and P. Gallo, Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.77, issue.8, pp.953-958, 2006.
DOI : 10.1136/jnnp.2005.086116

C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, pp.840-846, 2005.
DOI : 10.1212/WNL.53.6.1184

C. Polman, S. Reingold, B. Banwell, M. Clanet, J. Cohen et al., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011.
DOI : 10.1002/ana.21464

A. Postigo, R. Pulido, M. Campanero, A. Acevedo, A. García-pardo et al., Differential expression of VLA-4 integrin by resident and peripheral blood B lymphocytes. Acquisition of functionally active ??4??1-fibronectin receptors upon B cell activation, European Journal of Immunology, vol.249, issue.10, pp.2437-2482, 1991.
DOI : 10.1007/978-3-642-71272-2_3

M. Pugliatti, G. Rosati, H. Carton, T. Riise, J. Drulovic et al., The epidemiology of multiple sclerosis in Europe, European Journal of Neurology, vol.51, issue.2, pp.700-722, 2006.
DOI : 10.1093/heapol/16.3.326

M. Sandberg-wollheim, OPTIC NEURITIS: STUDIES ON THE CEREBROSPINAL FLUID IN RELATION TO CLINICAL COURSE IN 61 PATIENTS, Acta Neurologica Scandinavica, vol.58, issue.Suppl. 124, pp.167-78, 1975.
DOI : 10.1001/archneur.1969.00480080032003

A. Solomon, E. Klein, and D. Bourdette, "Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS, Neurology, vol.78, issue.24, pp.1986-91, 2012.
DOI : 10.1212/WNL.0b013e318259e1b2

R. Srivastava, M. Aslam, S. Kalluri, L. Schirmer, D. Buck et al., Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis, New England Journal of Medicine, vol.367, issue.2, pp.115-138, 1056.
DOI : 10.1056/NEJMoa1110740

S. Ramagopalan, A. Morris, D. Dyment, B. Herrera, G. Deluca et al., The Inheritance of Resistance Alleles in Multiple Sclerosis, PLoS Genetics, vol.26, issue.9, pp.1607-1620, 2007.
DOI : 1098-2272(2004)026[0186:POPAFG]2.0.CO;2

R. Ransohoff, Natalizumab for Multiple Sclerosis, New England Journal of Medicine, vol.356, issue.25, pp.2622-2631, 2007.
DOI : 10.1056/NEJMct071462

H. Reiber and K. Felgenhauer, Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system, Clinica Chimica Acta, vol.163, issue.3, pp.319-347, 1987.
DOI : 10.1016/0009-8981(87)90250-6

H. Reiber, Flow rate of cerebrospinal fluid (CSF) ??? A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases, Journal of the Neurological Sciences, vol.122, issue.2, pp.189-203, 1994.
DOI : 10.1016/0022-510X(94)90298-4

H. Reiber, Dynamics of brain-derived proteins in cerebrospinal fluid, Clinica Chimica Acta, vol.310, issue.2, pp.173-86, 2001.
DOI : 10.1016/S0009-8981(01)00573-3

H. Reiber, Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and sourcerelated dynamics, Restor Neurol Neurosci, vol.21, pp.3-479, 2003.

H. Reiber, M. Otto, C. Trendelenburg, and A. Wormek, Reporting Cerebrospinal Fluid Data: Knowledge Base and Interpretation Software, Clinical Chemistry and Laboratory Medicine, vol.21, issue.4, pp.324-356, 2001.
DOI : 10.1515/CCLM.2000.106

URL : http://www.horeiber.de/pdf/17.pdf

H. Reiber and J. Peter, Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs, Journal of the Neurological Sciences, vol.184, issue.2, pp.101-123, 2001.
DOI : 10.1016/S0022-510X(00)00501-3

G. Riccitelli, M. Rocca, E. Pagani, V. Martinelli, M. Radaelli et al., Mapping regional grey and white matter atrophy in relapsing???remitting multiple sclerosis, Multiple Sclerosis Journal, vol.18, issue.7, pp.1027-1064, 2012.
DOI : 10.1148/radiol.10100326

J. Rosenbluth, Z. Liu, D. Guo, and R. Schiff, Inhibition of CNS myelin developmentin vivo by implantation of anti-GalC hybridoma cells, Journal of Neurocytology, vol.34, issue.11, pp.699-707, 1994.
DOI : 10.1007/BF01181644

J. Rosenbluth, R. Schiff, W. Liang, W. Dou, and D. Moon, Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma, Journal of Neurocytology, vol.32, issue.3, pp.4-5397, 1999.
DOI : 10.1023/B:NEUR.0000010085.91976.a6

J. Rosenbluth, R. Schiff, W. Liang, and W. Dou, Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma, Journal of Neurocytology, vol.32, issue.3
DOI : 10.1023/B:NEUR.0000010085.91976.a6

S. Rossi, C. Motta, V. Studer, F. Monteleone, D. Chiara et al., A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation, Multiple Sclerosis Journal, vol.74, issue.1, pp.59-68, 2012.
DOI : 10.1007/s00415-009-5200-9

B. Runmarker and O. Andersen, Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up, Brain, vol.116, issue.1, pp.117-151, 1993.
DOI : 10.1093/brain/116.1.117

B. Sadatipour, J. Greer, and M. Pender, Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis, Annals of Neurology, vol.278, issue.6, pp.980-983, 1998.
DOI : 10.1212/WNL.46.4.907

A. Saiz, E. Carreras, J. Berenguer, J. Yagüe, C. Martínez et al., MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS, Neurology, vol.56, issue.8, pp.1084-1093, 2001.
DOI : 10.1212/WNL.56.8.1084

R. Schneider, B. Euler, and S. Rauer, Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event, European Journal of Neurology, vol.258, issue.8, pp.907-918, 2007.
DOI : 10.1191/1352458505ms1187sr

B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi, Detection of Ectopic B-cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis, Brain Pathology, vol.100, issue.2, pp.164-74, 2004.
DOI : 10.1172/JCI119622

M. Sharief and E. Thompson, The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis, Annals of Neurology, vol.43, issue.2, pp.147-51, 1991.
DOI : 10.1007/978-1-4613-0777-8_15

E. Silber, Y. Semra, N. Gregson, and M. Sharief, Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit, Neurology, vol.58, issue.9, pp.1372-81, 2002.
DOI : 10.1212/WNL.58.9.1372

C. Sindic and E. Laterre, Oligoclonal free kappa and lambda bands in the cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases, Journal of Neuroimmunology, vol.33, issue.1, pp.63-72, 1991.
DOI : 10.1016/0165-5728(91)90035-6

M. Trojano, M. Liguori, G. Bosco-zimatore, R. Bugarini, C. Avolio et al., Age-related disability in multiple sclerosis, Annals of Neurology, vol.67, issue.4, pp.475-80, 2002.
DOI : 10.1136/jnnp.67.2.148

L. Villar, P. González-porqué, J. Masjuán, J. Alvarez-cermeño, A. Bootello et al., A sensitive and reproducible method for the detection of oligoclonal IgM bands, Journal of Immunological Methods, vol.258, issue.1-2, pp.151-156, 2001.
DOI : 10.1016/S0022-1759(01)00492-6

L. Villar, J. Masjuan, P. González-porqué, J. Plaza, M. Sádaba et al., Intrathecal IgM synthesis in neurologic diseases: Relationship with disability in MS, Neurology, vol.58, issue.5, pp.824-830, 2002.
DOI : 10.1212/WNL.58.5.824

L. Villar, J. Masjuan, P. González-porqué, J. Plaza, M. Sádaba et al., Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS, Neurology, vol.59, issue.4, pp.555-564, 2002.
DOI : 10.1212/WNL.59.4.555

L. Villar, J. Masjuan, P. González-porqué, J. Plaza, M. Sádaba et al., Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis, Annals of Neurology, vol.5, issue.2, pp.222-228, 2003.
DOI : 10.1002/ana.410440621

L. Villar, M. Sádaba, E. Roldán, J. Masjuan, P. González-porqué et al., Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS, Journal of Clinical Investigation, vol.115, issue.1, pp.187-94, 2005.
DOI : 10.1172/JCI22833

L. Villar, N. García-barragán, M. Espiño, E. Roldán, M. Sádaba et al., Influence of oligoclonal IgM specificity in multiple sclerosis disease course, Multiple Sclerosis Journal, vol.14, issue.2, pp.183-190, 2007.
DOI : 10.1038/5532

L. Villar, T. Masterman, B. Casanova, J. Gómez-rial, M. Espiño et al., CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis, Journal of Neuroimmunology, vol.211, issue.1-2, 2009.
DOI : 10.1016/j.jneuroim.2009.03.003

L. Villar, M. Espiño, M. Cavanillas, E. Roldán, E. Urcelay et al., Immunological mechanisms that REVUES RÉFÉRENCES 1 Suppressor T cells: they're back and critical for regulation of autoimmunity, Immunol Rev, vol.182, pp.149-63, 2001.

S. Sakaguchi, M. Miyara, C. Costantino, and D. Hafler, FOXP3+ regulatory T cells in the human immune system, Nature Reviews Immunology, vol.34, issue.7, pp.490-500, 2010.
DOI : 10.4049/jimmunol.172.10.5967

K. Aschenbrenner, D. Cruz, L. Vollmann, and E. , Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells, Nature Immunology, vol.173, issue.4, pp.351-359, 2007.
DOI : 10.1186/1471-2172-7-6

M. Asano, M. Toda, N. Sakaguchi, and S. Sakaguchi, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation, Journal of Experimental Medicine, vol.184, issue.2, pp.387-96, 1996.
DOI : 10.1084/jem.184.2.387

S. Sakaguchi, N. Sakaguchi, and M. Asano, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25) Breakdown of a single mechanism of selftolerance causes various autoimmune diseases, J Immunol, vol.155, pp.1151-64, 1995.

S. Hori, T. Nomura, and S. Sakaguchi, Control of Regulatory T Cell Development by the Transcription Factor Foxp3, Science, vol.299, issue.5609, pp.1057-61, 2003.
DOI : 10.1126/science.1079490

D. Campbell and M. Koch, Phenotypical and functional specialization of FOXP3+ regulatory T cells, Nature Reviews Immunology, vol.177, issue.2, pp.119-149, 2011.
DOI : 10.4049/jimmunol.177.10.6983

W. Liu, A. Putnam, and Z. Xu-yu, T reg cells, The Journal of Experimental Medicine, vol.376, issue.7, pp.1701-1712, 2006.
DOI : 10.1016/S0092-8674(04)00127-8

M. Miyara, Y. Yoshioka, and A. Kitoh, Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor, Immunity, vol.30, issue.6, pp.899-911, 2009.
DOI : 10.1016/j.immuni.2009.03.019

D. Tran, J. Andersson, and R. Wang, GARP (LRRC32) is essential for the surface expression of latent TGF-?? on platelets and activated FOXP3+ regulatory T cells, Proceedings of the National Academy of Sciences, vol.9, issue.14, pp.13445-50, 2009.
DOI : 10.1016/S0002-9440(10)63458-X

J. Kim, J. Rasmussen, and A. Rudensky, Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice, Nature Immunology, vol.7, issue.2, pp.191-198, 2007.
DOI : 10.1038/ni1289

T. Malek, A. Yu, and V. Vincek, CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2R??-Deficient Mice, Immunity, vol.17, issue.2, pp.167-78, 2002.
DOI : 10.1016/S1074-7613(02)00367-9

J. Buckner, Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases, Nature Reviews Immunology, vol.3, issue.12, pp.849-59, 2010.
DOI : 10.4049/jimmunol.172.6.3580

G. Darrasse-jeze, A. Bergot, and A. Durgeau, Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice, Journal of Clinical Investigation, vol.119, pp.2648-62, 2009.
DOI : 10.1172/JCI36628DS1

URL : https://hal.archives-ouvertes.fr/hal-00420216

S. Maury, F. Lemoine, and Y. Hicheri, CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation, Science Translational Medicine, vol.25, issue.5, pp.41-52, 2010.
DOI : 10.1200/JCO.2006.09.2403

H. Nishikawa and S. Sakaguchi, Regulatory T cells in tumor immunity, International Journal of Cancer, vol.27, pp.759-67, 2010.
DOI : 10.4049/jimmunol.176.11.6434

P. Boros and J. Bromberg, Human FOXP3+ Regulatory T Cells in Transplantation, American Journal of Transplantation, vol.9, issue.8, pp.1719-1743, 2009.
DOI : 10.4049/jimmunol.178.12.7667

J. Cohen, A. Trenado, and D. Vasey, Immunoregulatory T Cells, The Journal of Experimental Medicine, vol.141, issue.3, pp.401-407, 2002.
DOI : 10.1016/S0167-5699(98)01420-0

URL : https://hal.archives-ouvertes.fr/hal-00018382

H. Mittrucker and S. Kaufmann, Mini-review: Regulatory T cells and infection: suppression revisited, European Journal of Immunology, vol.34, issue.2, pp.306-318, 2004.
DOI : 10.1002/eji.200324578

O. Palomares, G. Yaman, and A. Azkur, Role of Treg in immune regulation of allergic diseases, European Journal of Immunology, vol.206, issue.5, pp.1232-1272, 2010.
DOI : 10.4049/jimmunol.172.5.3252

L. Collison, C. Workman, and T. Kuo, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, vol.24, issue.7169, pp.566-575, 2007.
DOI : 10.4049/jimmunol.170.8.3939

B. Choi, H. Pae, and Y. Jeong, Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression, Biochemical and Biophysical Research Communications, vol.327, issue.4, pp.1066-71, 2005.
DOI : 10.1016/j.bbrc.2004.12.106

S. Deaglio, K. Dwyer, and W. Gao, Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, The Journal of Experimental Medicine, vol.261, issue.6
DOI : 10.1074/jbc.275.3.2057

T. Bopp, C. Becker, and M. Klein, Cyclic adenosine monophosphate is a key component of regulatory T cell???mediated suppression, The Journal of Experimental Medicine, vol.69, issue.6, pp.1303-1313, 2007.
DOI : 10.1084/jem.20041538

C. Piccirillo and E. Shevach, Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells, The Journal of Immunology, vol.167, issue.3, pp.1137-1177, 2001.
DOI : 10.4049/jimmunol.167.3.1137

W. Grossman, J. Verbsky, and W. Barchet, Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death, Immunity, vol.21, issue.4, pp.589-601, 2004.
DOI : 10.1016/j.immuni.2004.09.002

Y. Grinberg-bleyer, A. Baeyens, and S. You, IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells, The Journal of Experimental Medicine, vol.207, issue.9
DOI : 10.1038/ni.1774

M. Roncarolo, S. Gregori, and M. Battaglia, Interleukin???10???secreting type 1 regulatory T cells in rodents and humans, Immunological Reviews, vol.169, issue.1, pp.28-50, 2006.
DOI : 10.1067/mai.2003.1570

M. Levings and M. Roncarolo, Phenotypic and Functional Differences Between Human CD4+CD25+ and Type 1 Regulatory T Cells, Curr Top Microbiol Immunol, vol.293, pp.303-329, 2005.
DOI : 10.1007/3-540-27702-1_14

K. Wu, Y. Bi, K. Sun, and C. Wang, IL-10-producing type 1 regulatory T cells and allergy, Cell Mol Immunol, vol.4, pp.269-75, 2007.

T. Part, Siri m/s n° 8-9, p.2012

K. Tarbell, L. Petit, and X. Zuo, regulatory T cells restore normoglycemia in diabetic NOD mice, The Journal of Experimental Medicine, vol.344, issue.1, pp.191-201, 2007.
DOI : 10.1172/JCI23961

M. Miyara, Z. Amoura, and C. Parizot, Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus, The Journal of Immunology, vol.175, issue.12, pp.8392-400, 2005.
DOI : 10.4049/jimmunol.175.12.8392

K. Scalapino, Q. Tang, and J. Bluestone, Suppression of Disease in New Zealand Black/New Zealand White Lupus-Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells, The Journal of Immunology, vol.177, issue.3, pp.1451-1460, 2006.
DOI : 10.4049/jimmunol.177.3.1451

H. Uhlig, J. Coombes, and C. Mottet, Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis, The Journal of Immunology, vol.177, issue.9, pp.5852-60, 2006.
DOI : 10.4049/jimmunol.177.9.5852

M. Morgan, R. Flierman, and L. Van-duivenvoorde, Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells, Arthritis & Rheumatism, vol.104, issue.7, pp.2212-2233, 2005.
DOI : 10.4049/jimmunol.169.9.4712

X. Zhang, D. Koldzic, and L. Izikson, IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells, International Immunology, vol.16, issue.2, pp.249-56, 2004.
DOI : 10.1093/intimm/dxh029

E. Masteller, M. Warner, and Q. Tang, Expansion of Functional Endogenous Antigen-Specific CD4+CD25+ Regulatory T Cells from Nonobese Diabetic Mice, The Journal of Immunology, vol.175, issue.5, pp.3053-3062, 2005.
DOI : 10.4049/jimmunol.175.5.3053

W. Godfrey, Y. Ge, and D. Spoden, In vitro-expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures, Blood, vol.104, issue.2, pp.453-61, 2004.
DOI : 10.1182/blood-2004-01-0151

M. Levings, R. Sangregorio, and C. Sartirana, T Suppressor Cell Clones Produce Transforming Growth Factor ??, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells, The Journal of Experimental Medicine, vol.44, issue.10, pp.1335-1381, 2002.
DOI : 10.1084/jem.20020642

Q. Tang, K. Henriksen, and M. Bi, In Vitro???expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes, The Journal of Experimental Medicine, vol.161, issue.11, pp.1455-65, 2004.
DOI : 10.1016/S1521-6616(02)00017-7

S. Fisson, F. Djelti, and A. Trenado, Therapeutic potential of self-antigen-specific CD4+CD25+ regulatory T cells selectedin vitro from a polyclonal repertoire, European Journal of Immunology, vol.172, issue.4, pp.817-844, 2006.
DOI : 10.4049/jimmunol.172.10.6003

S. Jiang, N. Camara, G. Lombardi, and R. Lechler, Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo, Blood, vol.102, issue.6, pp.2180-2186, 2003.
DOI : 10.1182/blood-2003-04-1164

M. Battaglia, A. Stabilini, and B. Migliavacca, Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients, The Journal of Immunology, vol.177, issue.12, pp.8338-8385, 2006.
DOI : 10.4049/jimmunol.177.12.8338

H. Tilg, C. Van-montfrans, and A. Van-den-ende, Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma, Gut, vol.50, issue.2, pp.191-196, 2002.
DOI : 10.1136/gut.50.2.191

F. Barrat, D. Cua, and A. Boonstra, T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)??? and Th2-inducing Cytokines, The Journal of Experimental Medicine, vol.153, issue.5, pp.603-619, 2002.
DOI : 10.1002/1521-4141(200009)30:9<2639::AID-IMMU2639>3.0.CO;2-7

URL : http://jem.rupress.org/content/jem/195/5/603.full.pdf

H. Groux, O. Garra, A. Bigler, and M. , A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, vol.389, issue.6652, pp.737-779, 1997.
DOI : 10.1007/978-3-662-22038-2_16

A. Wakkach, N. Fournier, and V. Brun, Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo, Immunity, vol.18, issue.5, pp.605-622, 2003.
DOI : 10.1016/S1074-7613(03)00113-4

R. Bacchetta, S. Gregori, and G. Serafini, Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy, Haematologica, vol.95, issue.12, pp.2134-2177, 2010.
DOI : 10.3324/haematol.2010.025825

V. Brun, H. Bastian, V. Neveu, and A. Foussat, Clinical grade production of IL-10 producing regulatory Tr1 lymphocytes for cell therapy of chronic inflammatory diseases, International Immunopharmacology, vol.9, issue.5, pp.609-622, 2009.
DOI : 10.1016/j.intimp.2009.01.032

L. Zhou, M. Chong, and D. Littman, Plasticity of CD4+ T Cell Lineage Differentiation, Immunity, vol.30, issue.5, pp.646-55, 2009.
DOI : 10.1016/j.immuni.2009.05.001

N. Komatsu, M. Mariotti-ferrandiz, and Y. Wang, T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity, Proceedings of the National Academy of Sciences, vol.106, issue.6, pp.1903-1911, 2009.
DOI : 10.1073/pnas.0702004104

URL : https://hal.archives-ouvertes.fr/hal-00407810

H. Kim and W. Leonard, 73 CREB/ATF-Dependent T-cell Receptor-Induced FoxP3 Gene Expression: A Role for DNA Methylation, Cytokine, vol.39, issue.1, pp.1543-51, 2007.
DOI : 10.1016/j.cyto.2007.07.078

R. Tao, E. De-zoeten, and E. Ozkaynak, Deacetylase inhibition promotes the generation and function of regulatory T cells, Nature Medicine, vol.90, issue.11, pp.1299-307, 2007.
DOI : 10.4049/jimmunol.166.2.973

D. Mekala and T. Geiger, Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes, Blood, vol.105, issue.5, pp.2090-2092, 2005.
DOI : 10.1182/blood-2004-09-3579

F. Urnov, J. Miller, and Y. Lee, Highly efficient endogenous human gene correction using designed zinc-finger nucleases, Nature, vol.100, issue.7042, pp.646-51, 2005.
DOI : 10.1073/pnas.2035056100

B. Salomon, D. Lenschow, and L. Rhee, B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes, Immunity, vol.12, issue.4, pp.431-471, 2000.
DOI : 10.1016/S1074-7613(00)80195-8

M. Mirabel, B. Ferreira, and D. Sidi, Rhumatisme articulaire aigu, m??decine/sciences, vol.134, issue.6-7, pp.633-641, 2012.
DOI : 10.1016/j.ijcard.2008.12.110

URL : http://www.medecinesciences.org/articles/medsci/pdf/2012/08/medsci2012286-7p633.pdf